Patent details

Basic Information

Publication number:

EP2038306

PCT Application Number:

PCT/EP/2007/056485

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP077868859

PCT Publication Number:

WO/2008/009545

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-NKG2A ANTIBODIES AND USES THEREOF

French Title of Invention:

ANTICORPS ANTI-NKG2A ET LEURS UTILISATIONS

German Title of Invention:

ANTI-NKG2A-ANTIKÖRPER UND IHRE ANWENDUNG

SPC Number:

Dates

Filing date:

28/06/2007

Grant date:

03/12/2014

EP Publication Date:

03/12/2014

PCT Publication Date:

24/01/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/03/2009

EP B1 Publication Date:

03/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/06/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/06/2007

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Agent

Name:

ARONOVA S.A.

From:

24/02/2015

Address:

PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

SPEE Petrus Johannes Louis

Address:

Denmark (DK)

2

Name:

PADKÆR Søren Berg

Address:

Denmark (DK)

Priority

Priority Number:

06116429

Priority Date:

30/06/2006

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07K 16/28;

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

13/06/2024

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages